27 April 2023
Latham & Watkins Advises TA Associates in Its Investment in Diatech Pharmacogenetics
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stefano Sciolla Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Giorgia Lugli Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Federica Ventura | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Nicholas Luraghi | Latham & Watkins LLP | Not stated | corporate | Not stated |
| Cesare Milani | Latham & Watkins LLP | Partner | regulatory | Not stated |
| Edoardo Cassinelli | Latham & Watkins LLP | Not stated | regulatory | Not stated |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- TA AssociatesInvestor
- Counterparties
- Diatech Pharmacogenetics (Target)